Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Masimo CorporationNASDAQ: MASI

EPS (Basic) · Q1 FY2026 · quarter ended Apr 2026

EPS (Basic) turns positive

Q1 FY2026 EPS (Basic) was $1.1, compared with -$3.17 a year earlier. Trailing-twelve-month EPS (Basic) was $1.44.

Context

  • EPS (Basic) increased in 1 of the last 3 fiscal years.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 2 analysts of $6 (+311.8%) for the fiscal year ending Jan 2027, a step up from the +50.5% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterApr 2026
$1.1-12.0% QoQ
Last fiscal yearJan 2026
-$2.83+50.5% YoY
LTMApr 2026
$1.44+115.6% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+134.7%+50.8%-83.9 pp
1 year+50.5%+311.8%+261.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(2.83) USD
Year-over-year change
+50.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +115.6% is the 2nd highest of 11, against a peer median of -17.2%.
MASI Competitors
EPS (Basic) for MASI and competitors
Company Period LTM YoY 3-year CAGR
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$8.33 USD-29.2%—
ATRAptarGroup, Inc.LTM Jun 2026$5.6 USD-5.2%+17.7%
HSICHenry Schein, Inc.LTM Jun 2026$3.46 USD+10.2%-5.9%
MASIMasimo CorporationLTM Apr 2026$1.44 USD+115.6%—
RGENRepligen CorporationLTM Jun 2026$0.74 USD+825.0%-36.2%
STVNStevanato Group S.p.A.LTM Jun 2026€0.48 EUR-4.0%-2.6%
MOHMolina Healthcare, Inc.LTM Sep 2026-$0.61 USD-103.8%-13.3%
AVTRAvantor, Inc.LTM Jun 2026-$0.84 USD-182.7%—
BAXBaxter International Inc.LTM Jun 2026-$2.04 USD-603.3%—
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026-$2.9 USD+6.5%—
ABVXAbivax S.A.FY2025-€4.65 EUR-66.1%—
Peer median (excluding MASI) —-17.2%-5.9%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue1.24B2.04B2.05B2.09B1.53B
Cost of Revenue430.8M977M1.04B1.09B581.7M
Gross Profit808.4M1.06B1B1B945.2M
Gross Margin65.2%52.0%49.0%48.0%61.9%
Research & Development137.2M191.4M175.2M222.8M126.4M
Selling, General & Admin395.4M657.4M664M743.8M506M
Operating Expenses532.6M848.8M867M1.27B632.4M
Depreciation & Amortization35.6M136.1M98.3M103M38.8M
EBITDA310.3M355.2M236.7M(158.7M)344.6M
EBITDA Margin25.0%17.4%11.6%-7.6%22.6%
Operating Income275.8M210M136.5M(266.7M)312.8M
Operating Margin22.3%10.3%6.7%-12.7%20.5%
Interest Income900K1.8M3M4.8M3.4M
Interest Expense300K25.7M50.3M43.6M33.2M
Other Income / Expenses(1.4M)(16.6M)(48.4M)(38.6M)(40.2M)
Income Before Tax274.4M193.4M88.1M(305.3M)272.6M
Pre-Tax Margin22.1%9.5%4.3%-14.6%17.9%
Income Tax Expense44.8M49.9M6.6M(400K)64.9M
Net Income229.6M143.5M81.5M(304.9M)(151.5M)
Net Margin18.5%7.0%4.0%-14.6%-9.9%
EPS (Basic)4.162.681.54(5.72)(2.83)
EPS (Diluted)3.982.601.51(5.72)(2.80)
Weighted Avg Shares55.17M53.6M52.8M53.3M53.6M
Weighted Avg Shares (Diluted)57.68M55.2M54.1M53.3M54.2M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.